Floatz logo

Moderna Bivalent Mrna Vaccine

Organ Transplantation

Monash UniversityvaccinePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Organ Transplantation cohort.

Asset / SponsorPhaseRating
TACROLIMUS
University of Illinois at Chicago
Phase 4BBB
CYCLOSPORIN A
Fernanda P Silveira, MD, MS
Phase 4BBB
Rapamycin
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4BBB
Busulphan
M.D. Anderson Cancer Center
Phase 3BB
Fludarabine
M.D. Anderson Cancer Center
Phase 3BB

View all 33 →

Same molecule, other indications

Moderna Bivalent Mrna Vaccine is also rated in:

COVID-19Dormant
B
Indicative ·
60 / 100
View asset →
HIV infectious diseaseDormant
B
Indicative ·
60 / 100
View asset →
non-Hodgkin lymphomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →